Effect of piplartine and cinnamides on Leishmania amazonensis, Plasmodium falciparum and on peritoneal cells of Swiss mice

References

• Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M. 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 7:e35671.
   PubMed Web of Science ®Google Scholar
• Adams DJ, Dai M, Pellegrino G, Wagner BK, Stern AM, Shamji AF, Schreiber SL. 2012. Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs. Proc Natl Acad Sci USA. 109:15115–15120.
   PubMed Web of Science ®Google Scholar
• Beteck RM, Smit FJ, Haynes RK, N'Da DD. 2014. Recent progress in the development of anti-malarial quinolones. Malar J. 13:339–348.
   PubMed Web of Science ®Google Scholar
• Bezerra DP, Pessoa C, de Moraes MO, Saker-Neto N, Silveira ER, Costa-Lotufo LV. 2013. Overview of the therapeutic potential of piplartine (Piperlongumine). Eur J Pharm Sci. 48:453–463.
   PubMed Web of Science ®Google Scholar
• Bézivin C, Tomasi S, Lohézic-Le DF, Lohézic-Le Dévéhat F, Boustie J. 2003. Cytotoxic activity of some lichen extracts on murine and human cancer cell lines. Phytomedicine. 10:499–503.
   PubMed Web of Science ®Google Scholar
• Bodiwala HS, Singh G, Singh R, Singh CS, Dey SS, Sharma KK, Bhutani IP. 2007. Antileishmanial amides and lignans from Piper cubeba and Piper retrofractum. Nat Med. 61:418–421.
   Google Scholar
• Braz RM, Duarte EC, Tauil PL. 2013. Characteristcs of malaria epidemics in the municipalities of the Brazilian Amazon. Cad Saúde Púb. 29:935–944.
   PubMed Web of Science ®Google Scholar
• Brand GD, Leite JRSA, de Sa Mandel SM, Mesquita BA, Silva LP, Prates MV, Barbosa EA, Vinecky F, Martins GR, Galasso JH, Kuckelhaus SAS, Sampaio RN, Furtado JR. 2006. Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia). Biochem Biophys Res Commun. 47:739–746.
   Google Scholar
• Burrows JM, Burlot E, Campo B, Burrows JN, Cherbuin S, Jeanneret S, Leroy D, Spangenberg T, Waterson D, Wells TN, Willis P. 2014. Antimalarial drug discovery - the path towards eradication. Parasitology. 141:128–139.
   PubMed Web of Science ®Google Scholar
• Clark MA, Goheen MM, Cerami C. 2014. Influence of host iron status on Plasmodium falciparum infection. Front Pharmacol. 5:1–12.
   PubMed Web of Science ®Google Scholar
• Cotinguiba F, Regasini LO, Bolzani VS, Debonsi HM, Passerini GD, Sicarelli RMB, Kato MJ, Furlan M. 2009. Piperamides and their derivatives as potential anti-trypanosomal agents. Med Chem Res. 18:703–711.
   Web of Science ®Google Scholar
• Flores N, Jiménez IA, Giménez A, Ruiz G, Gutiérrez D, Bourdy G, Bazzocchi IL. 2008. Benzoic acid derivatives from Piper species and their antiparasitic activity. J Nat Prod. 71:1538–1543.
   PubMed Web of Science ®Google Scholar
• Fokoue HH. Síntese, atividades biológicas e estudo de relação de estrutura-atividade de piperamidas. [Internet]. 2015. São Paulo. [Cited 2016 June 20]. Available from: http://www.teses.usp.br/teses/disponiveis/46/46136/tde-25032015-105445/pt-br.php.
   Google Scholar
• Ginsburg H, Ward SA, Bray PG. 1999. An integrated model of chloroquine action. Parasitol Today. 15:357–360.
   PubMedGoogle Scholar
• Glickman MH, Ciechanover A. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 82:373–428.
   PubMed Web of Science ®Google Scholar
• Gomes AP, Vitorino RR, Costa AP, Costa AP, Mendonça EG, Oliveira MGA, Siqueira-Batista R. 2011. Severe Plasmodium falciparum malaria. Rev Bras Ter Intensiva. 23:358–369.
   PubMedGoogle Scholar
• Handler MZ, Patel PA, Kapila R, Al-Qubati Y, Schwartz RA. 2015. Cutaneous and mucocutaneous leishmaniasis: clinical perspectives. J Am Acad Dermatol. 73:897–908.
   PubMed Web of Science ®Google Scholar
• Houghton PJ, Howes MJ, Lee CC, Steventon G. 2007. Uses and abuses of in vitro tests in ethnopharmacology: visualizing an elephant. J Ethnopharmacol. 110:391–400.
   PubMed Web of Science ®Google Scholar
• Jarvius M, Fryknäs M, D′Arcy P, Sun C, Rickardson L, Gulbo J, Haglund C, Nygren P Linder S, Larsson R. 2013. Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells. Biochem Biophys Res Commun. 431:117–123.
   PubMed Web of Science ®Google Scholar
• Monzote L. 2009. Current treatment of Leishmaniasis: a review. Open Antimicrob Agents J. 1:9–19.
   Google Scholar
• Moraes JD, Nascimento C, Lopes PO, Lopes POMV, Nakano E, Yamaguchi LF, Kato MJ, Kawano T. 2011. Schistosoma mansoni: In vitro schistosomicidal activity of piplartine. Exp Parasitol. 127:357–364.
   PubMed Web of Science ®Google Scholar
• Muniz-Junqueira MI, Prata A, Tosta CE. 1997. Factors influencing phagocytosis of Salmonella typhimurium by macrophages in murine schistosomiasis. Rev Soc Bras Med Trop. 30:101–106.
   PubMedGoogle Scholar
• Muniz-Junqueira MI. 2007. Immunomodulatory therapy associated to anti-parasite drugs as a way to prevent severe forms of malaria. Curr Clin Pharmacol. 2:59–73.
   PubMedGoogle Scholar
• Muñoz C, Francisco JS, Gutiérrez B, González J. 2015. Role of the ubiquitin-proteasome systems in the biology and virulence of protozoan parasites. Biomed Res Int. 2015:1–13.
   Web of Science ®Google Scholar
• Oliveira-Ferreira J, Lacerda MV, Brasil P, Ladislau JLB, Tauil PL, Daniel-Ribeiro CL. 2010. Malaria in Brazil: an overview. Malar J. 9:1–15.
   PubMed Web of Science ®Google Scholar
• Olliaro PL, Goldberg DE. 1995. The Plasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol Today. 11:294–297.
   PubMedGoogle Scholar
• Parmar VS, Jain SC, Bisht KS, Jain R, Taneja P, Jha A, Tyagi OM, Prasad AK, Wengel J, Olsen CE, Boll PM. 1997. Phytochemistry of the genus Piper. Phytochemistry. 46:597–673.
   Web of Science ®Google Scholar
• Pham TT, Loiseau PM, Barrat G. 2013. Strategies for the design of orally bioavailable antileishmanial treatments. Int J Pharm. 454:539–552.
   PubMed Web of Science ®Google Scholar
• Rahman NNNA, Furuta T, Kojima S, Najib Nik A Rahman N, Takane K, Ali Mohd M. 1999. Antimalarial activity of extracts of Malaysian medicinal plants. J Ethnopharmacol. 64:249–254.
   PubMed Web of Science ®Google Scholar
• Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, et al. 2011. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature. 475:231–234.
   PubMed Web of Science ®Google Scholar
• Rao VR, Muthenna P, Shankaraiah G, Akileshwari C, Babu KH, Suresh G, Babu KS, Chandra Kumar RS, Prasad KR, Yadav PA, et al. 2012. Synthesis and biological evaluation of new piplartine analogues as potent aldose reductase inhibitors (ARIs). Eur J Med Chem. 57:344–361.
   PubMed Web of Science ®Google Scholar
• Silva-Jardim I, Horta MF, Ramalho-Pinto FJ. 2004. The Leishmania chagasi proteasome: role in promastigotes growth and amastigotes survival within murine macrophages. Acta Trop. 91:121–130.
   PubMed Web of Science ®Google Scholar
• Schonian G, Maurício I, Cupolillo E. 2010. Is it time to revise the nomenclature of Leishmania? Trends Parasitol. 26:466–469.
   PubMed Web of Science ®Google Scholar
• Schonian G, Kuhls K, Maurício L. 2011. Molecular approaches for a better understanding of the epidemiology and population genetics of Leishmania. Parasitology. 138:405–425.
   PubMed Web of Science ®Google Scholar
• Sullivan DJ. 2002. Theories on malarial pigment formation and quinoline action. Int J Parasitol. 32:1645–1653.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Shi M, Qiu Q. 2016. Piperlongumine suppresses dendritic cell maturation by reducing production of reactive oxygen species and has therapeutic potential for rheumatoid arthritis. J Immunol. 196:4925–4934.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2016. World Malaria Report. [Internet]. [cited 2016 June 18]. Available from: http://www.who.int/topics/malaria/en/.
   Google Scholar